LY-3541105

N/A

Report date: 2025/07/01 16:15:28

Base Information

Drug NameLY-3541105
Drug Alias NameLY-3541105Dacra-QW-II
ClassificationBiologics
Mechanisms of ActionCalcitonin receptor agonistsAmylin receptor agonists
TargetsCalcitonin receptorAmylin Receptor
Therapy Area/IndicationsOverweight
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsOverweight
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A